Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 357 for “"RANKL"”.
-
RANKL From Osteocytes Contributes to Periodontal Bone Loss
… The ligand for the receptor activator of NF-κB (RANKL) induces the differentiation of osteoclasts, resulting in periodontal bone loss. The role of osteocytes in periodontal bone loss was investigated in this study. Transgenic mice expressing RANKL under the control of dentin matrix protein 1 …
-
RANKL and Osteoprotegerin Levels in Response to Orthodontic Forces
… activator nuclear factor kappa B ligand (RANKL)—is critical for osteoclastogenesis, and osteoprotegerin (OPG) is a decoy ligand that competitively inhibits RANKL. A higher RANKL/OPG ratio is associated with areas of bone resorption, while a lower ratio occurs in areas of bone deposition …
-
Modulation of RANKL and Osteoprotegerin in Adolescents Using Orthodontic Forces
… activator nuclear factor kappa B ligand (RANKL)--is critical for osteoclastogenesis, and osteoprotegerin (OPG) is a decoy ligand that competitively inhibits RANKL. A higher RANKL/OPG ratio is associated with areas of bone resorption, while a lower ratio occurs in areas of bone deposition …
-
Prevention of rebound bone loss following withdrawal of RANKL inhibition
Denosumab is a potent inhibitor of RANKL-mediated osteoclast formation and activity, increasing BMD and reducing fracture risk. This has revolutionised treatment of osteoporosis and other skeletal conditions where suppression of bone resorption is required. However, discontinuation leads to a …
-
B lymphocyte RANKL enhances periodontal disease in type 2 diabetes
… activator of nuclear factor kappa-B ligand (RANKL), which is a key element for osteoclastogenesis and periodontal related bone loss. Previous studies have looked at PD or T2D but not together within the context of inflammation. To further understand the impact of T2D potentiated periodontal …
-
Effect RANKL Produced by Periodontal Ligament Cells on Orthodontic Tooth Movement
… Receptor activator of nuclear factor-κB ligand (RANKL) is essential for osteoclast formation and differentiation. Several cell types have been reported to be capable of producing RANKL. We are interested in whether there is a dominant cell type which RANKL production is critical in generating …
-
Μελέτη του ρόλου του γονιδίου RANKL στην Παθογένεια της Πνευμονικής Ίνωσης
… της. Πρόσφατα βρέθηκε η έκφραση των γονιδίων RANKL/RANK/OPG σε συγκεκριμένα κύτταρα ιστών ποντικών με πνευμονική ίνωση και ο ρόλος της αναλογίας RANKL/OPG στην ασθένεια. Ο βασικός ρόλος των μορίων αυτών είναι η ρύθμιση του οστικού μεταβολισμού. H RANKL (receptor activator of NF-kB ligand) …
-
Μελέτη του παθογενετικού ρόλου της κυτταροκίνης RANKL σε διαγονιδιακά ζωικά πρότυπα
Receptor activator of NF-κBligand (RANKL) plays a key role in osteoclast-induced bone resorption across a range of degenerative bone diseases, and its specific inhibition has been recently approved as a treatment for women with postmenopausal osteoporosis at high or increased risk of fracture. In …
-
An investigation into the role of RANKL and sclerostin in dentoalveolar ankylosis
… a major source of receptor activator of NF-κβ (RANKL) which is essential for osteoclastogenesis. This project aims to investigate the expression of RANKL and sclerostin in a rat model of dentoalveolar ankylosis induced by a hypothermal insult. The null hypothesis is that an applied cold insult …
-
Μελέτη του παθοφυσιολογικού ρόλου της πρωτεΐνης RANKL στον μαστικό αδένα διαγονιδιακών ποντικών
… and the primary cause of death in women. RANKL (Receptor Activator of Nuclear Factor κB Ligand) has been identified as the main mediator of mammary gland development by progesterone during pregnancy, and recent data implicate it in hormone-induced breast cancer. This doctoral thesis …
-
Μελέτη του συμπλέγματος rankl / οστεοπροτεγερίνης και ορμονικών παραμέτρων σε αιμοκαθαιρόμενους νεφροπαθείς ασθενείς
… to the pathogenesis of renal bone disease. RANKL/OPG complex is one of the major modulators of bone remodelling and appears to mediate the effects of a number of humoral factors related to the development of renal osteodystrophy. The aim of the present study was the evaluation of RANKL/OPG …
-
In vitro cell models of vascular calcification: integrative roles for RANKL and TRAIL
… namely receptor-activator of NF-κB ligand (RANKL) and tumour necrosis factor-related apoptosis-inducing ligand (TRAIL), interact with each other to regulate the calcification process. Whilst it is clear that RANKL promotes VC, in part via endothelial paracrine signalling, the precise role of …
-
Statins Regulate IL-1β - Induced RANKL and OPG Production by Human Gingival Fibroblasts
… first one, receptor activator for NF- kB ligand (RANKL) is expressed on hematopoetic stromal cells and periosteal osteoblasts as well as on HGF and PDL cells. RANKL interacts with its corresponding receptor, RANK, on mononucleated osteoclast precursors and induces their activation to multinuclear …
-
Wnt Secretion Proteins Modulate RANKL-Induced Expression of Aire in Thymic Epithelial Cells
… developing thymocytes and instead use exogenous RANKL to drive TEC specific maturation, while simultaneously culture the TECs with different Wnt proteins. Our results show that the Wnt antagonist, Sfrp-1, and the Wnt ligand, Wnt-5b, interfere with RANKL-induced maturation as demonstrated by a …
-
Estudo da associação dos genes RANk, RANKL e OPG com a osteopatia diabética
… de RNAm e os polimorfismos dos genes RANK, RANKL e OPG de crianças, adolescentes e adultos jovens com DM1, bem como estudar a associação dos mesmos com o desenvolvimento de alterações no metabolismo ósseo.No total, foram incluídos no estudo 119 crianças e adolescentes com DM1 e 161 …
-
Μελέτη RANKL-επαγόμενων παθογενετικών μηχανισμών σε γενετικά ζωικά πρότυπα και νέες θεραπευτικές προσεγγίσεις
… diseases, such as osteoporosis. The cytokine RANKL(Receptor Activator of Nuclear Factor kB Ligand), a TNF superfamily member(Tumor Necrosis Factor), is the main mediator in the process of bone resorption as itinduces differentiation, survival and activity of osteoclasts. As trimer RANKL …
Page 1 of 18